Enhanced expression of "muscle-specific" actin in glomerulonephritis. Increased expression of "muscle-specific" actin can be correlated with mesangial cell injury and proliferation in the rat. We performed similar immunohistochemical studies using two monoclonal antibodies (MoAb) to "muscle-specific" actins (HHF-35, a MoAb to pan muscle actin and a-SM-I, a MoAb to a-smooth muscle actin) on methyl Carnoy's fixed human renal biopsies which demonstrated a wide variety of inflammatory, proliferative, and non-proliferative glomerular diseases. Most glomerular diseases were associated with increased "smooth-muscle" actin expression. Exceptions almost invariably were disease settings without prominent cellular proliferation. As in the rat, there was a correlation of induced actin expression with increased glomerular cell proliferation, as detected by staining with a MoAb to proliferating cell nuclear antigen (PCNA). Double immunolabeling studies with an antibody to the leukocyte common antigen showed the great majority of PCNA proliferating cells to be intrinsic glomerular cells rather than infiltrating leukocytes. These studies demonstrate that phenotypic changes of mesangial cells occur in both human and experimental glomerulonephritis, and are identifable in fixed tissue sections. These studies also suggest that markers of mesangial cell injury or activation and proliferation, such as immunostaining of renal biopsies for "muscle-specific" actins, might be useful diagnostic and/or prognostic indicators in proliferative or sclerosing glomerular diseases.
© 1992 by the International Society of Nephrology liferate may be studied under defined conditions [1] [2] [3] . Our understanding of these processes in vivo is much more limited, and specifically there has been little consistent identification of phenotypic changes in mesangial cells in human disease. One of the few studies which have addressed this issue has demonstrated an increase in myosin in glomeruli of patients with diabetic nephropathy and some forms of glomerulonephritis [4, 5] .
Recent studies of rodent models of glomerulonephritis by our group have shown that injury that results in mesangial cell proliferation (anti-Thy 1 antibody, Habu snake venom, Concanavalin A/anti-Concanavalin A antibody models) also results in increased expression of "muscle-specific" actins (principally smooth muscle actin) by mesangial cells [6] . "Muscle-specific" actins are those isoforms of the intracellular microfilament actin whose expression is thought to be specific to distinct types of muscle cells (smooth muscle cr-actin, smooth muscle y-actin, striated muscle a-actin, and cardiac muscle a-actin) [7, 8] . We have demonstrated that this increased expression of smooth muscle-actins in some models of injury is tightly linked to glomerular cell proliferation by virtue of its temporal correlation and by showing that experimental maneuvers that block the cell proliferation will also prevent the upregulation of a-smooth muscle actin gene expression and protein production in the glomeruli [6] . Further, as yet preliminary, studies by our group using a protocol of systemic infusion of angiotensin II into rodents indicates that in other settings, such as with increased intraglomerular pressure, the enhanced expression of smooth muscle actin isoforms occurs and may be dissociated from concomitant mesangial cell proliferation (Note added in proof).
In this study, we have investigated the relevance of these observations to human disease by utilizing similar phenotypic analyses of human biopsy tissue. Our finding that modest basal expression of "muscle-specific" actins in mesangial cells may be found in uninjured, apparently normal kidneys is demonstrative of a close ontogenetic relationship between mesangial cells and smooth muscle cells, We show that these actins can usually be detected in the mesangium in any form of glomerular injury, and that markedly increased expression is common in such proliferative glomerulonephridities as diffuse proliferative lupus nephritis and acute glomerulonephritis. Finally, as suggested by our studies in rodents, this study demonstrates a correlation between mesangial smooth muscle cs-actin expression and proliferation of cells within the glomerulus. Hence, it appears that enhanced expression of "muscle-specific" actins may be a useful phenotypic marker of mesangial injury and/or activation in human disease.
Methods

Source of tissue
Normal human kidney tissue (N = 9) was obtained from kidneys surgically excised because of the presence of a localized neoplasm. Tissues utilized for this study were obtained from macroscopically normal portions of kidney located at some distance from the neoplastic process. Additional normal tissue was obtained from fresh cadaver kidneys unable to be utilized for transplantation (N = 3).
Diseased human kidney was studied from a consecutive series of renal biopsies obtained over a two year period (1983 to 1984 at the University of Washington). Biopsies were excluded from this study for the following reasons: (a) tissue submitted in inappropriate fixative; (2) insufficient tissue remaining after completion of diagnostic workup; (3) fewer than three glomeruli remaining in tissue sections available for immunohistochemical studies. Biopsies in which the only diagnosis obtainable was nonspecific nephrosclerosis or end-stage renal disease were not considered; likewise, because of difficulty in interpreting results, biopsies with more than one pathologic process present (such as diabetic nephropathy and post-infectious glomerulonephritis) were also excluded from this study. The remaining 116 cases with acceptable tissue were studied. These cases were obtained from patients with a broad range of renal diseases (Table 1) .
There were two cases (one of minimal change disease, one of focal and segmental glomerulosclerosis) which only had evaluations for "muscle-specific" actins due to inability to achieve technically satisfactory PCNA immunostaining prior to exhaustion of the tissue.
Fixation
All tissues were fixed in methyl Carnoy's solution (60% methanol, 30% chloroform, 10% acetic acid) and processed and embedded in paraffin utilizing conventional techniques [91.
Immunohistochemistry
Sections of methyl Carnoy's fixed tissue were deparaffinized with Histoclear (National Diagnostics, Highland Park, New Jersey, USA) and graded ethanols, blocked with 0.3% hydrogen peroxide and 0,1% sodium azide, and washed with PBS (138 mM NaCI, 2.7 m KCI, 3.2 mMNa2HPO4, 1.5 mrvi KH2PO4 pH 7.3) containing 0.1% BSA (Sigma Chemical Co., St. Louis, Missouri, USA) and 0.01% Triton X-100. The tissue was then incubated with one of the primary murine monoclonal antibodies (see below), and subsequently processed using a streptavidin-biotin immunoperoxidase method with 3,3 '-diaminobenzidine (with nickel chloride enhancement) as the chromogen. Sections were counterstained with methyl green.
Antibodies
Three murine monoclonal anti-muscle antibodies were used for immunohistochemical evaluation. Anti-cr-SM-I 1101, with specificity for the smooth muscle a-actin isoform (gift of G. Gabbiani) and HHF-35 [II], reactive with all four "musclespecific" actin isoforms (smooth muscle a and y, cardiac muscle a, and striated muscle a actin isoforms) have been well characterized previously. A murine monoclonal antibody to human desrnin (DAKO Corp., Carpinteria, California, USA), Methyl Carnoy's fixed, paraffin embedded surgical biopsies from the fourteen cases with highest glomerular proliferation indices were sectioned and mounted on aminopropylmethoxysilane (APTS) coated slides. After deparaffinization and rehydration, the sections were incubated for five minutes with 3% hydrogen peroxide to inhibit endogenous peroxide reaction. They were then incubated with 10% normal goat serum for 30 minutes at room temperature (rt). Without rinsing the slides, the excess normal goat serum was removed and anti-PCNA antibody (Coulter Corp.), diluted at 4°C in a humid chamber.
Following PBS washes, the sections were incubated with goatanti-mouse 1gM-gold (Auroprobe LM GAMIgM, Amersham, Arlington Heights, Illinois, USA) (1:40 dilution in PBS containing 1% BSA and 0.1% gelatin) for one hour at room temperature. Sections were washed and the gold was visualized with a silver enhancement reaction kit (IntenSE M, Amersham). The sections were then incubated sequentially with anti-CD45 (DAKO Crop.; 1:50 dilution, 60 mm, rt), biotinylated horse anti-mouse IgG (Vector, Burlingame, California, USA; 1:200 dilution, 30 mi rt), and avidin-biotin-peroxidase complex (Vector; 30 mm, rt). The peroxidase was developed with a diaminobenzidine substrate solution and then counterstained with methyl green. Negative controls included omitting either the PCNA or the CD45 antibody in the staining procedure.
Statistical analysis
Values are expressed as the mean SE. Comparison of actin and PCNA values between disease (all categories) and nondisease controls was performed using the Mann-Whitney U test. ANOVA was used for pairwise comparisons of group means, using the Tukey method to adjust for multiple comparisons. Correlation of actin and PCNA values was performed using the actual PCNA value plus a constant 0.5 transformed to a natural logarithmic scale, which reduced heteroscedasticity and identified a more linear relationship with actin values.
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Results "Muscle-specic" actin expression in normal and diseased kidneys The distribution of scores by individual cases for reactivity with the a-smooth muscle actin antibody in all cases utilized in this study is given in Table 1 , with illustrations of typical glomerular actin expression patterns shown in Figure 1 . Also given are the scores for each individual glomerulus examined within the given disease categories. The values obtained with the HHF-35 pan-muscle actin antibody were essentially similar, although in general staining appeared slightly more intense with the a-smooth muscle actin antibody. Because of the generally congruent staining with these two antibodies, and because of the narrower specificity of the a1-smooth muscle actin antibody, it seems likely that much of the actin reactivity detected by HHF-35 is directed against the smooth muscle isoform recognized by the a-SM-i antibody, although activity against the y-smooth muscle actin isoform cannot be excluded. We therefore consider that immunoreactivity for either of the antibodies to "muscle-specific" actins in the glomerulus is in fact reactivity for "smooth muscle" actin. Descriptive statistical summary of the actin findings is given in Table 2 .
Normal kidneys. While some normal kidneys were without detectable levels of glomerular a-smooth muscle actin expression, this was not always the case. As indicated in Table I , most kidneys contained some glomeruli that showed focal, modest smooth muscle actin expression of l-2 intensity in mesangial areas. The typical appearance of glomeruli expressing either none or modest smooth muscle actin expression is shown in Kidneys with glomerulopathies. Representative illustrations of a-smooth muscle actin expression in various glomerulopathies are presented in Figure 1 . By histologic analysis, glomerular actin expression is virtually always mesangial in location regardless of disease type. Only in cases where the expression of this isoform is most intense, as illustrated in Figures 1D and IE, is it not possible to exclude a component of concomitantly induced expression of this protein in glomerular endothelial cells or visceral epithelial cells. In general, the distribution and intensity of actin expression within glomeruli was closely correlated, that is, weak or modest actin expression (l-2 intensity) most often was seen in only one or two lobules of a glomerulus while more intense (3k) staining typically involved more than half of the lobules present (Fig. lC) . Some variability in actin expression was seen in individual glomeruli within any given biopsy. In all cases, biopsies were assigned the highest actin score obtained by any of the glomeruli within them. While uniformity of expression was more readily seen in glomeruli from biopsies with high actin scores, our approach does not reflect the heterogeneity of expression that was seen in a number of the cases assigned lower actin scores (2 or less). This heterogeneity was frequent in some categories such as minimal change disease or normal kidneys where a positive actin score may be assigned on the basis of staining that is present in only a minority of the glomeruli within the biopsy, with most being unreactive with the anti-muscle-actin antibodies. The extent of heterogeneous expression of a-actin can be assessed by inspection of that portion of Table I in which the actin scores for all of the glomeruli within each disease category are given.
Although not a focus of this particular study, Figures lB-E also illustrate that a population of interstitial cells, present between the peritubular microvasculature and tubular basement membranes, also commonly express the a-smooth muscle actin isoform.
The extent of smooth muscle actin expression in the various disease categories studied is given in Table 1 . When actin expression in all glomerulopathies regardless of diagnosis was compared with basal actin expression detected in the normal controls (Table 2) , statistically significant elevation of actin expression was demonstrable in the diseased group (MannWhitney test, P = 0.015).
Pairwise comparison of actin expression by disease category resulted in a statistically significant difference (P < 0.05) between mean actin levels in the normal and diffuse proliferative lupus nephritis groups. This is a finding of interest but not clearly established, as the statistical method of comparison requires assumptions about the distributions of the populations tested that are not strictly met in this study. In essence, as indicated in Tables I and 2 , there is a trend for actin expression to be highest in those disease groups with the highest degree of cellular proliferation as normally detected histologically as well as by direct quantitation with the PCNA antibody as detailed below. But because of the considerable heterogeneity of actin expression within disease groups, the samples are not sufficiently large to achieve statistical significance. The typical appearance of glomeruli and adjacent tubulointerstitial tissue stained for PCNA is illustrated in Figure 2, illustrating absence of proliferation and prominent proliferative activity respectively. The mean cell proliferation indices by disease category are given in Table 2 . All normal kidneys exhibited a cell proliferation index of <0.15 positive cells! glomerular cross section. When PCNA scores for all disease categories combined are compared with those of the normal groups, the differences are statistically significant (Mann-Whitney, P < 0.004).
Actin and log PCNA had a statistically significant correlation coefficient of 0.457 (P < 0.001, one sample t-test). The results, illustrated in the box plot graph of Figure 3 , indicate that regardless of diagnosis, there is a general linear correlation between glomerular a-smooth muscle actin expression and glomerular cellular proliferation.
Accordingly, the highest cell proliferation index values were concentrated in those glomerulopathies with highest expression of a-smooth muscle actin and conventionally thought of as proliferative glomerulonephritis (acute glomerulonephritis, diffuse proliferative lupus nephritis, and membranoproliferative glomerulonephritis). The one disease category with surprisingly high PCNA expression was that of amyloidosis, a disease not usually thought to be characterized by cellular proliferation. In some cases of amyloidosis there was elevated glomerular actin expression as well. Double immunolabeling studies Double immunolabeling was performed with antibodies reactive with PCNA and with LCA in the fourteen cases having the highest glomerular proliferative indices as detected by staining with the anti-PCNA antibody alone. There was nearly complete separation between those glomerular cells expressing the leukocyte common antigen and PCNA cells, with greater than 95% of PCNA cells unreactive with the antibody to LCA. Of interest was the finding that in the interstitium, aggregates of infiltrating LCA expressing mononuclear inflammatory cells contained a small proportion of cells that were also reactive with the antibody to PCNA, indicative of intrarenal leukocyte proliferation. Discussion "Muscle-specific" actins are any of four isoforms of the intracellular microfilament actin (smooth muscle a-actin, smooth muscle '-actin, striated muscle a-actin, cardiac muscle a-actin) [7, 8, 14] . These isoforms can be distinguished from the cytoplasmic /3 and y actin isoforms, which are widely distributed in nucleated cells, by their mobility on electrophoretic gels and by differing epitopes which can be recognized by currently available monoclonal antibodies. It is generally accepted that cellular expression of "muscle-specific" actins implies cellular derivation from either smooth muscle, cardiac muscle, or skeletal muscle, depending on the actin isoform expressed. This is a useful construct with which to approach phenotypic studies of tissue injury, but we remain cautious in the unequivocal acceptance of this idea because examples of anomalous, low level expression of these actin isoforms have been observed in non-muscle derived cells both in vivo and in vitro [14] [15] [16] [17] [18] [19] . Our use of quotation marks with the term muscle-specific is meant to reflect this element of uncertainty as to the absoluteness of the relationship between actin isoform expression and muscle derivation.
The findings of this study were established by using two distinct, well characterized antibodies specifically reactive with muscle actin isoforms. Both of these antibodies have been characterized by Western blotting, and both have been investigated in a variety of disease processes using the tissue immunocytochemical procedures employed in this study [10, 11, 14, 19] . Neither has ever been shown to be cross reactive with matrix proteins by either Western blot or tissue localization studies. Previous localization studies in rat models of mesangial injury by our group have shown cellular localization of the HHF-35 muscle actin specific antibody by immunoelectron microscopy [6] , and demonstrated that immunohistochemical detection of increased actin expression is correlated with induction of actin mRNA by Northern analysis. Finally, preliminary observations on human kidney using immunoelectron microscopy has provided further support for the conclusion that the extraglomerular renal interstitial reactivity seen with both of these antibodies is confined to a population of interstitial cells (Alpers CE et al, manuscript in preparation).
A major finding in this study is the demonstration that "muscle-specific" actins, and specifically a-smooth muscle actin, can usually be detected in the mesangium in any form of glomerular injury, These actins are less regularly but still frequently present in the mesangium of histologically normal kidneys obtained from patients without known renal disease other than localized tumors. In the case of normal kidneys, expression of "muscle-specific" actins, when present, is often focal and sparse, and is never associated with a grade higher than 2. It is not known if those normal kidneys with a-smooth muscle actin expression are truly "normal"; that is, if these kidneys may have come from patients with minor or unrecognized conditions such as mild hypertension or other disease processes. Nonetheless, this finding does provide additional evidence for the postulate that mesangial cells may have a close ontogenetic relationship with pericytes and/or smooth muscle cells, cell types which characteristically express the a-smooth muscle actin isoform [7, 8, 20] .
Glomerular mesangial cells, in normal or diseased kidneys, were uniformly without detectable expression of desmin. In agreement with these results, studies by two groups of investigators also could not demonstrate the presence of desmin in normal or diseased human mesangium [21, 22] . However, one other group has localized desmin to normal human mesangium with an immunofluorescence technique 123]. Differences in sensitivity or dilutions of the antibodies employed may account for these differences, and the possibility that mesangial cells express low levels of desmin not readily detectable by tissue immunohistochemistry cannot be excluded. The significance of our findings is unknown, but studies by a number of others have shown that desmin expression in both a relatively specific and a relatively insensitive marker of smooth muscle cells [24, 25] .
The present findings are in keeping with a concept of the mesangial cell as smooth muscle cell-like, but still maintaining its own distinctive phenotypic features.
In contrast to normal kidneys, enhanced expression of "muscle-specific" actins, and specifically a-smooth muscle actin, both in intensity and distribution, is a sensitive marker of mesangial injury detectable in fixed tissue sections. As seen in Table 1 , enhanced expression may be seen in any form of glomerular injury, and markedly increased expression is common in proliferative glomerulonephritis such as diffuse proliferative lupus glomerulonephritis and acute glomerulonephritis. This finding closely follows that obtained in studies of immune complex mediated mesangial injury in the rat, where marked expression of a-smooth muscle actin by mesangial cells correlates with the onset of proliferation [6] . Alternatively, we found a few cases of diffuse glomerulonephritis as determined by diffuse patterns of immune complex deposition (such as lupus nephritis) which had low levels of a-smooth muscle actin expression. Our review of such cases showed that they were noteworthy even at the time of initial diagnosis because they were almost always associated with little cellular proliferation, a finding then thought discrepant with the extent of immune complex deposition that was demonstrable by immunofluorescence and electron microscopy. As discussed below, these findings in aggregate suggest that in general there is a strong association between a-smooth muscle actin expression and cellular proliferation in the glomerulus.
An unexpected finding of interest was that pronounced expression (that is, grade 3 or higher) of a-smooth muscle actin may be seen in mesangiopathic conditions not previously associated with cellular proliferation such as amyloidosis and nodular diabetic glomerulosclerosis. The finding of high actin expression in some cases of diabetes, which were without other evidence of superimposed inflammatory injury, is indicative of an altered physiologic state of mesangial cells in this setting. The second major finding in the present study, which also is consistent with prior studies in the rat, is that there is a correlation between high a-smooth muscle actin expression and glomerular cell proliferation, as detected by reactivity of gbmerular cells with an antibody to PCNA [6] . This finding is somewhat remarkable in that unlike the controlled experimental situation in the rat, where conditions and the timing of biopsies are controlled and hence impart a certain uniformity to morphologic injury, our study of human biopsies necessarily includes lesions within diagnostic categories at all stages of initiation and progression. This feature probably accounts in part for the variability of proliferative indices obtained between individual cases within specific disease groups. Although shown in several studies to be a good marker of cellular proliferation [12, 13, 27 -301 one potential caveat with PCNA staining is that it could conceivably react with cells that have entered the cell cycle but undergone subsequent arrest of their progression through cell division. In this scenario, expression of PCNA could at times be an additional marker of cell activation without necessarily indicating cell division.
The significance of our findings is not yet known, It is tempting to speculate that increased levels of a-smooth muscle actin expression and acquisition of a more muscle-like phenotype by mesangial cells in disease states may affect mesangial cell contractility and hence contribute to the altered hemodynamics encountered in glomerular injury [31] . The studies of Floege et al noted above suggest the possibility that finding prominent a-smooth muscle actin expression in some human biopsies may reflect active production by mesangial cells of matrix, which may be reflected in the chronic sclerosing lesions encountered in amyloidosis and diabetic nephropathy. While it would be premature to identify enhanced expression of a-smooth muscle actin as a marker of active mesangial remodeling or scarring, histologic identification of such markers may have eventual clinical utility. For example, recent experimental investigations in the rat suggest that diseases associated with mesangial cell matrix production may eventually be targeted for therapeutic interventions such as administration of anti-transforming growth factor-a antibody [321, and it is to be hoped that such therapies may one day be employed in appropriately identified cases of human disease.
It is also possible that enhanced expression of a-smooth muscle actin, or other as yet unidentified markers of mesangial injury or activation, may have prognostic significance in specific disease states. Obvious examples where a potential association might be found are in the identification of those subsets of patients with minimal change disease who subsequently develop focal and segmental glomerulosclerosis, and those patients with IgA nephropathy who develop glomerulosclerosis. Studies to evaluate such possibilities are currently being pursued.
In conclusion, these studies demonstrate that enhanced expression of "muscle-specific" actins is a sensitive, albeit non-specific, marker of mesangial injury detectable in fixed tissue sections of human renal biopsies. In many cases, this enhanced expression also is a marker for cellular proliferation within glomeruli. We believe that identification of this expression in renal biopsies, as well as potential additional markers of altered phenotype of glomerular cells, may eventually prove to have diagnostic or prognostic significance in the assessment of human glomerular diseases.
